Skip to main content
ABUS logo

ABUS · Arbutus Biopharma Corp · Share Buybacks

Track ABUS — free
$4.02 -0.05 (-1.23%) At close · Nov 20 Q3 2024 earnings call transcript
Market Cap
$616.24M
Shares
153.29M
Volume · Nov 20 2.99M Avg daily vol (3M) 5.19M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$230,000,000
as of 2026-09-30 · from Press release (reviewed)· expired 2026-09-29
Program Announced Authorized Remaining Runs Through
2026-08-21 $230,000,000 — 2026-09-29 expired
2026-07-16 $230,000,000 — —
Key facts CIK 1447028 CUSIP 03879J100 13F (30d) 221 filings 200 filers Visit website Investor relations